Trial intelligence / Profile preview

CHIARA MIA oral chymase inhibitor study after acute myocardial infarction

MOH_2017-02-09_000102Phase 2Completed

Sponsor
Bayer
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in left ventricular dysfunction (LVD) and myocardial infarction (MI) comparing BAY 1142524 plus standard care with Placebo plus standard care (2 arms). Started Oct 2016; status: completed.

02

Drugs

fulacimstat
03

Conditions

left ventricular dysfunction (LVD)myocardial infarction (MI)

Beyond the preview

Go deeper on MOH_2017-02-09_000102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2017-02-09_000102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call